Document Detail

Induction of hemeoxygenase-1 attenuates the hypertension and renal inflammation in spontaneously hypertensive rats.
MedLine Citation:
PMID:  20667508     Owner:  NLM     Status:  In-Process    
The reno-protective mechanisms of hemeoxygenase-1 (HO-1) induction in hypertension remain unclear. We hypothesize that induction of HO-1 will decrease blood pressure and proteinuria with a marked decrease in oxidative stress and inflammation in spontaneously hypertensive rats (SHR). Male Wistar Kyoto (WKY) and SHR were injected with the HO-1 inducer cobalt protoporphyrin (CoPP, 1.5 mg/kgs.c. twice weekly) which resulted in an increase in renal HO-1 expression after 2 weeks. CoPP reduced mean arterial pressure (133±2 mmHg vs. 144±4 mmHg, p<0.05) and proteinuria (14±1 mg/day vs. 24±2 mg/day, p<0.05) in SHR as compared to baseline values, with no effect in WKY. Renal cortical superoxide (O(2)(-)) production and urinary 8-isoprostane excretion were higher in SHR compared to WKY (O(2)(-): 11±1 CPM/μg vs. 6±1 CPM/μg protein, p<0.05; 8-iso: 7±1 ng/day vs. 3±0.8 ng/day, p<0.05) and CoPP attenuated oxidative stress levels only in SHR (O(2)(-): 5±1 CPM/μg, p<0.05; 8-isoprostane: 4±0.7 ng/day) without an overall effect on antioxidant defense enzymes expression and activities. SHR showed a marked elevation in plasma C-reactive protein (CRP) and urinary monocyte chemoattractant protein-1 (MCP-1) excretion compared with WKY and HO-1 induction reduced the CRP and MCP-1 levels in SHR. Cortical COX2 expression and urinary thromboxane B(2) (TXB(2)) excretion were also significantly elevated in SHR compared to WKY and levels were reduced with induction of HO-1. Inhibition of HO with stannous mesoporphyrin further increased blood pressure and proteinuria in SHR and blocked the ability of CoPP to reduce blood pressure and proteinuria in SHR. These data demonstrate that induction of HO-1 slows the progression of hypertension and proteinuria in SHR and these changes were associated with reduced renal oxidative stress and inflammation.
Ahmed A Elmarakby; Jessica Faulkner; Sam P Posey; Jennifer C Sullivan
Related Documents :
8842568 - Attenuation of intrinsic active tone by endothelium-derived nitric oxide in aortae of s...
7315428 - Structurally reduced distensibility of cardiovascular low-pressure' compartments in pri...
3029218 - Mechanism of action of a new prostaglandin antihypertensive, viprostol [cl 115 347; (dl...
1608038 - Effects of a new dihydropyridine derivative, frc-8653, on blood pressure in conscious s...
20825358 - Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensi...
20926988 - The effect of the intrathoracic pressure regulator on hemodynamics and cardiac output.
Publication Detail:
Type:  Journal Article     Date:  2010-08-05
Journal Detail:
Title:  Pharmacological research : the official journal of the Italian Pharmacological Society     Volume:  62     ISSN:  1096-1186     ISO Abbreviation:  Pharmacol. Res.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-09-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8907422     Medline TA:  Pharmacol Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  400-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Ltd. All rights reserved.
Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Multivariate wavelet texture analysis for pharmaceutical solid product characterization.
Next Document:  Wot the 'L-Does MutL do?